The Europe Electronic Clinical Outcome Assessment Solution Market (eCOA) would witness market growth of 18.6% CAGR during the forecast period (2020-2026).
Electronic-based services for data capturing & analyzing effectively beat every limitation of paper-based procedures, with a surge in patient compliance. With the help of these solutions, the risk of data variance can be eliminated & site monitoring costs can be reduced. These solutions provide simplified information that helps in enhancing the quality of data by gathering the information in an organized manner. These factors would act as drivers for the growth of the eCOA market during the forecast period. The requirement for incorporation of patient care into clinical research results in a patient-centric approach being deployed by sponsors, which causes an increment in the installation of eCOA platforms.
The adoption & demand for eCOA solutions would be fuelled due to the complexity of healthcare information management. Using these systems, healthcare facilities can expect accurate & timely delivery of health information & decrease the pressure of patients who are undergoing clinical trials. The demand for R&D to create innovative treatments & drugs is increasing with the massive growth of the healthcare industry. The increasing number of research studies is creating a need for a unified data capture system. Therefore, all the mentioned aspects would drive the product demand during the forecast period.
There is a paradigm shift from paper-based procedures to electronic data capturing systems. This is owing to the increasing burden on pharmaceutical companies to reduce overall costs for the development of a new drug. The data capturing through eCOA platforms enhance the quality of the information obtained, centralizes the data collection methods, and provides valuable insights to its users such as data analysis.
Based on Delivery Mode, the market is segmented into Web-hosted eCOA, Cloud-based eCOA, and Licensed enterprises eCOA. Based on End Use, the market is segmented into Contract Research Organizations (CROs), Hospitals, Academic Institutes, Pharma & Biotech Companies and Medical Device Manufacturers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Germany market dominated the Europe Academic Institutes Market by Country in 2019, thereby, achieving a market value of $25 Million by 2026. The UK market is showcasing a CAGR of 17.7% during (2020 - 2026). Additionally, The France market is poised to grow at a CAGR of 19.1% during (2020 - 2026).
Free Valuable Insights: Electronic Clinical Outcome Assessment (eCOA) Market in Europe is expected to register a CAGR of 18.6% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, Dassault Systemes SE, IQVIA Holdings, Inc., Parexel International Corporation (Pamplona Capital Management), IBM Corporation (Merge Healthcare), Signant Health, ERT Clinical, eClinical Solutions LLC, Castor EDC and Anju Software, Inc. (OmniComm Systems).
By Delivery Mode
By End-Use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
